Published in Br J Pharmacol on November 01, 2001
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol (2008) 3.39
The SLC22 drug transporter family. Pflugers Arch (2003) 1.95
Regulation of ACh release from guinea pig bladder urothelial cells: potential role in bladder filling sensations. Br J Pharmacol (2014) 1.42
Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol (2008) 1.42
Drug transporters in the human blood-placental barrier. Br J Pharmacol (2009) 1.30
Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci (2007) 1.27
The epithelial cholinergic system of the airways. Histochem Cell Biol (2008) 1.17
Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse. Respir Res (2006) 0.96
Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells. Biochem Pharmacol (2006) 0.85
In vivo release of non-neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin. Br J Pharmacol (2006) 0.84
Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi. Br J Pharmacol (2011) 0.84
Chemical coding and chemosensory properties of cholinergic brush cells in the mouse gastrointestinal and biliary tract. Front Physiol (2015) 0.84
Expression of choline and acetylcholine transporters in synovial tissue and cartilage of patients with rheumatoid arthritis and osteoarthritis. Cell Tissue Res (2014) 0.83
Effects of acetylcholinesterase inhibitor paraoxon denote the possibility of non-quantal acetylcholine release in myocardium of different vertebrates. J Comp Physiol B (2011) 0.83
Acetylcholine and the alpha 7 nicotinic receptor: a potential therapeutic target for the treatment of periodontal disease? Inflamm Res (2012) 0.82
Expression of the cholinergic gene locus in the rat placenta. Histochem Cell Biol (2004) 0.80
"Tasting" the airway lining fluid. Histochem Cell Biol (2012) 0.80
Luminal cholinergic signalling in airway lining fluid: a novel mechanism for activating chloride secretion via Ca²⁺-dependent Cl⁻ and K⁺ channels. Br J Pharmacol (2012) 0.80
Signalling molecules in the urothelium. Biomed Res Int (2014) 0.79
Immunoglobulin G from breast cancer patients in stage I stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide. J Clin Immunol (2010) 0.79
Acetylcholine released by endothelial cells facilitates flow-mediated dilatation. J Physiol (2016) 0.78
Cholinergic activity as a new target in diseases of the heart. Mol Med (2015) 0.78
Permissive role of calcium on regulatory volume decrease in freshly isolated mouse cholangiocytes. Pflugers Arch (2007) 0.77
Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia. Front Pharmacol (2016) 0.75
Placental control of drug delivery. Adv Drug Deliv Rev (2016) 0.75
Personalized genetics of the cholinergic blockade of neuroinflammation. J Neurochem (2017) 0.75
Bioelectric gene and reaction networks: computational modelling of genetic, biochemical and bioelectrical dynamics in pattern regulation. J R Soc Interface (2017) 0.75
Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther (1998) 1.99
Drug excretion mediated by a new prototype of polyspecific transporter. Nature (1994) 1.77
The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol (1999) 1.68
Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem (1998) 1.59
Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol (1998) 1.56
Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.47
Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol (1999) 1.47
Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol (1998) 1.44
Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem (1998) 1.42
Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem (1998) 1.31
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther (1999) 1.29
Biological functions of keratinocyte cholinergic receptors. J Investig Dermatol Symp Proc (1997) 1.27
Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther (2000) 1.25
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther (1999) 1.24
cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun (1996) 1.18
Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem (1997) 1.15
Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol (1998) 1.08
Cholinergic systems in non-nervous tissues. Pharmacol Rev (1978) 1.07
Acetylcholine in isolated airways of rat, guinea pig, and human: species differences in role of airway mucosa. Am J Physiol (1996) 0.99
Human placental cholinergic system. Biochem Pharmacol (1997) 0.98
A reevaluation of substrate specificity of the rat cation transporter rOCT1. J Biol Chem (1997) 0.92
Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.91
Muscarinic cholinergic binding sites on rat lymphocytes. Immunopharmacology (1989) 0.85
Release of non-neuronal acetylcholine from the human placenta: difference to neuronal acetylcholine. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.82
Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol (1995) 0.82
Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins. J Cardiovasc Pharmacol (1986) 0.78
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature (1995) 10.13
Ribosomal RNA transcription in vitro is species specific. Nature (1982) 4.78
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol (1996) 4.45
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol (1992) 3.85
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol (2008) 3.39
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc Natl Acad Sci U S A (1994) 3.00
C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism. Biophys J (1995) 2.97
K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature (1984) 2.89
Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev (1989) 2.66
Vertical strabismus after cataract surgery. Ophthalmology (1996) 2.56
Recovery from C-type inactivation is modulated by extracellular potassium. Biophys J (1996) 2.52
Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia (2003) 2.02
Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther (1998) 1.99
L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation (1997) 1.75
Pegylation: a method for assessing topological accessibilities in Kv1.3. Biochemistry (2001) 1.74
Voltage-gated potassium conductance in human T lymphocytes stimulated with phorbol ester. J Physiol (1986) 1.70
The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol (1999) 1.68
Inhibition by oxotremorine of acetylcholine resting release from guinea pig-ileum longitudinal muscle strips. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.63
Ringer's lactate solution and extracellular fluid volume in the surgical patient: a critical analysis. Ann Surg (1969) 1.63
Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Mol Biol Cell (2007) 1.60
Mechanisms of cell activation by heavy metal ions. J Biomed Mater Res (1998) 1.58
Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth (2003) 1.57
Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis. Endoscopy (2008) 1.54
Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.47
Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1989) 1.44
Physicochemical behaviour and structural characteristics of membrane-bound acetylcholinesterase from Torpedo electric organ. Effect of phosphatidylinositol-specific phospholipase C. Biochem J (1985) 1.42
Interaction between nutrition, interleukins, and the NO-arginine system. Nutrition (1996) 1.41
Thiopentone, thiopentone/ketamine, and ketamine for induction of anaesthesia in caesarean section. Eur J Anaesthesiol (1994) 1.39
Cellular hydration state: an important determinant of protein catabolism in health and disease. Lancet (1993) 1.38
The non-neuronal cholinergic system of human skin. Horm Metab Res (2007) 1.34
The Non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther (2001) 1.33
Generation of human pulmonary microvascular endothelial cell lines. Lab Invest (2001) 1.31
Temperature dependence of K(+)-channel properties in human T lymphocytes. Biophys J (1990) 1.29
Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med (1993) 1.27
Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res (1996) 1.26
Dose-related effects of shock waves on rabbit tendo Achillis. A sonographic and histological study. J Bone Joint Surg Br (1998) 1.26
Modulation by oxotremorine and atropine of acetylcholine release evoked by electrical stimulation of the myenteric plexus of the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.24
Increased voltage-gated potassium conductance during interleukin 2-stimulated proliferation of a mouse helper T lymphocyte clone. J Cell Biol (1986) 1.24
Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer (1992) 1.22
T1-T1 interactions occur in ER membranes while nascent Kv peptides are still attached to ribosomes. Biochemistry (2001) 1.22
Regulation of intracellular pH by human peripheral blood lymphocytes as measured by 19F NMR. Proc Natl Acad Sci U S A (1982) 1.21
Inhibition by acetylcholine of the stimulation-evoked release of [3H]acetylcholine from the guinea-pig myenteric plexus. Neuroscience (1980) 1.21
Cellular energy metabolism, trans-plasma and trans-mitochondrial membrane potentials, and pH gradients in mouse neuroblastoma. Proc Natl Acad Sci U S A (1979) 1.20
A voltage-dependent role for K+ in recovery from C-type inactivation. Biophys J (1996) 1.19
Volume response of quiescent and interleukin 2-stimulated T-lymphocytes to hypotonicity. Am J Physiol (1988) 1.19
Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects. Eur J Clin Invest (1988) 1.18
Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol (1985) 1.18
Truncated K+ channel DNA sequences specifically suppress lymphocyte K+ channel gene expression. Biophys J (1995) 1.18
Voltage-gated K+ channels contain multiple intersubunit association sites. J Biol Chem (1996) 1.17
Inhibition of human detrusor contraction by a urothelium derived factor. J Urol (2003) 1.17
Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15
Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol (2008) 1.15
Intracellular Ca2+ pools in Jurkat T-lymphocytes. Biochem J (1993) 1.15
gamma-Aminobutyric acid and cholinergic transmission in the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.15
Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clin Infect Dis (2000) 1.15
Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.14
A sodium requirement for mitogen-induced proliferation in human peripheral blood lymphocytes. Exp Cell Res (1981) 1.14
Transmembrane biogenesis of Kv1.3. Biochemistry (2000) 1.14
Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.14
Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder. J Pharmacol Exp Ther (1986) 1.13
Muscarinic modulation of acetylcholine release evoked by dimethylphenylpiperazinium and high potassium from guinea-pig myenteric plexus. Eur J Pharmacol (1978) 1.12
The biological role of non-neuronal acetylcholine in plants and humans. Jpn J Pharmacol (2001) 1.12
The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol (1999) 1.12
Evidence for dimerization of dimers in K+ channel assembly. Biophys J (1999) 1.12
Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis. Cancer (1997) 1.12
Elimination of amino acids in renal failure. Am J Clin Nutr (1994) 1.10
Complete gangrene of penis in patient with arterial vascular disease. Urology (2004) 1.09
Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med (1998) 1.09
Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum. Eur J Pharmacol (1984) 1.08
Diverse K+ channels in primary human T lymphocytes. J Gen Physiol (1992) 1.08
Microtiter assay for acetylcholinesterase. Anal Biochem (1987) 1.07
PCR testing for Treponema pallidum in paraffin-embedded skin biopsy specimens: test design and impact on the diagnosis of syphilis. J Clin Pathol (2007) 1.07
Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus. Br J Pharmacol (1985) 1.07
Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects. Evid Rep Technol Assess (Summ) (2003) 1.07
Transhepatic metabolism of TNF-alpha, IL-6, and endotoxin in the early hepatic reperfusion period after human liver transplantation. Transplantation (1994) 1.07
Spacer sequences downstream of the 28S RNA coding region are part of the mouse rDNA transcription unit. Nucleic Acids Res (1985) 1.06
Endothelialization of a non-woven silk fibroin net for use in tissue engineering: growth and gene regulation of human endothelial cells. Biomaterials (2004) 1.06
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology (1989) 1.06
The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.05
Human submandibular saliva aggregates HIV. AIDS Res Hum Retroviruses (1993) 1.05
Natural history of Gardner's syndrome. Am J Surg (1968) 1.05
Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock (1999) 1.05
Short- and long-term effects of training phonological awareness in kindergarten: evidence from two German studies. J Exp Child Psychol (1997) 1.05
Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease. Virchows Arch (2004) 1.04
Cell calcium in human peripheral blood lymphocytes and the effect of mitogen. Biochim Biophys Acta (1982) 1.04
Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.04
Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo. J Immunol (2000) 1.04
Pre- and postsynaptic effects of muscarinic agonists in the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol (1980) 1.04
The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer (2001) 1.04
Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects. Pediatrics (1983) 1.04
Resting energy expenditure in short-term starvation is increased as a result of an increase in serum norepinephrine. Am J Clin Nutr (2000) 1.04
Current trends in biocompatibility testing. Proc Inst Mech Eng H (1998) 1.03
Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? J Pathol (2000) 1.03
Use of a collagen/elastin-membrane for the tissue engineering of dermis. Burns (1999) 1.03
Forskolin effects on the voltage-gated K+ conductance of human T cells. Pflugers Arch (1988) 1.03